All News

A review of past literature on topical corticosteroid phobia in atopic dermatitis sought to better understand a phenomenon that is a major factor in treatment failure.

There is an association between the rising generic drug prices and the changing levels of market competition, according to a study published in Annals of Internal Medicine.

The age a woman experiences natural menopause is associated with her risk of developing type 2 diabetes.

In a study designed to identify the relevant cost per number needed to treat for the 2 biological disease-modifying antirheumatic drugs tocilizumab (TCZ) and abatacept, researchers determined that TCZ had a higher efficacy.

There are multiple factors that can affect how patients respond to treatment or how their health is maintained. One that is gaining more attention is how social interactions can benefit a person’s health.

Luminaries from the worlds of research, regulation, and advocacy in diabetes gathered in Bethesda, Maryland, to discuss what future rules for drug and device approvals might look like if things like hypoglycemia and time in range had consideration.

CMS announced it will hold a meeting to gather input on potential models to pay for behavioral healthcare that would improve quality, expand access, and lower costs for beneficiaries.

This week, the top managed care stories included more twists in Senate Republicans' efforts to repeal the Affordable Care Act; a Medicare fraud sweep targeted opioid distribution; and the CDC reported 30 million Americans now have diabetes.

Coverage of our peer-reviewed research in the healthcare and mainstream press.

Social interaction during chemotherapy treatments can positively influence a cancer patient’s health through improving patient outcomes and patient survival rates.

In a webinar hosted by Carevive, researcher Ethan Basch, MD, MSc, discussed the findings of his recent study linking electronic patient-reported outcomes (PROs) to better survival outcomes for patients with cancer.

The data confirm what Medicaid beneficiaries report and what a study by a Wharton School professor found: physicians' willingness to take on Medicaid patients is directly related to reimbursement rates.

The study found that no matter their eating pattern, participants tended to add weight gradually until age 60, then lose it gradually. But those who had most of their calories earlier in the day gained less and lost weight more rapidly after age 60.

Researchers at the University of Pennsylvania have recognized that narrow provider networks are quite likely to exclude National Cancer Institute—Designated Cancer Centers or National Comprehensive Cancer Network Cancer Centers, which could prevent patient access to high-quality cancer care.

In a recently released position statement, the American Society of Clinical Oncology (ASCO) has outlined a pathway that would address the rising costs of cancer drugs in the United States.

The FDA recently approved Vosevi-a fixed-dose combination tablet containing FDA-approved sofosbuvir and velpatasvir, and a new drug, voxilaprevi-to treat adults with the hepatitis C virus who do not have cirrhosis (liver disease).

The majority of patients with chronic obstructive pulmonary disease (COPD) do not receive positive airway pressure (PAP) therapy despite its effectiveness in reducing hospitalizations, according to research.

Researchers at the Beth Israel Deaconess Medical Center in Boston investigated the impact of patient engagement in evaluating their care visit notes and found patients and care partners who chose to provide feedback were enthusiastic about assisting with improving the accuracy of clinician notes.

The National Quality Forum (NQF) has issued a report detailing the results of its experiment with including social risk factors in its risk adjustment models for performance measures.

If there's good news, it's that the rate of increase in number of individuals with diabetes seems to be slowing. But the disease is hitting hardest on the populations with the fewest resources to manage it.

Another showdown is looming between a leading academic medical center and a payer it seemingly can’t live without, and once again it’s about Medicaid.

Report notes that 74% of drugs that are currently in development are potentially first-in-class medicines, and 822 drugs in development are for rare diseases.

According to findings from a 63-center international study, published in the New England Journal of Medicine, complete lymph node excision may not be essential for improved outcomes in melanoma.

The FDA has approved neratinib (Nerlynx) for the extended adjuvant treatment of some forms of breast cancer, but recommends precautions against the common side effect of diarrhea.

The report foresees the rules for durable medical equipment becoming increasingly inadequate to keep pace with technology advances, and wants a review of policies.